Skip to content

Enhancing Mucosal Clarity During Esophagogastroduodenoscopy: Effectiveness of Preprocedural Saliva Management Guidance

Enhancing Mucosal Clarity During Esophagogastroduodenoscopy: Effectiveness of Preprocedural Saliva Management Guidance

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400091425
Enrollment
Unknown
Registered
2024-10-28
Start date
2023-11-02
Completion date
Unknown
Last updated
2024-11-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Upper gastrointestinal neoplasms

Interventions

Experimental group:Instruct the patients to avoid swallowing
Control group:No instruction

Sponsors

Department of Gastroenterology, Xiamen Hongai Hospital, Fujian Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: Both male and female adult (>18 years) patients who provided written informed consent were included in the study

Exclusion criteria

Exclusion criteria: (1) Gastroscopy contraindicated; (2) Esophageal stenosis and upper digestive tract reconstruction after operation; (3) Pregnant and lactating women; (4) Allergic to simethicone and Streptomyces protease; (5) any candidate deemed unsuitable by the study physician;

Design outcomes

Primary

MeasureTime frame
The primary outcome was mucosal total visibility scores.;

Secondary

MeasureTime frame
Number of lesions found;Water consumption ;

Countries

China

Contacts

Public ContactXuyuan Ma

Department of Gastroenterology, Xiamen Hongai Hospital, Fujian Medical University

maxuyuan0206@163.com+86 137 2089 2152

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026